How One Man’s Psychedelic Journey May Change the Face of Schizophrenia Treatment



BY:
CANNABIS CULTURE – “It is well understood that people with schizophrenia should not take large dosages of psychedelics because it is destabilizing,” says Mark Haden, Executive Director of the Multidisciplinary Association for Psychedelic Studies (MAPS) in Canada.  “But we don’t know the effect of small dosages and how that can impact them.” The future of psychosis treatment took a new turn when Haden met a young man named “John Doe,” who had experience in microdosing…
BY:



DON'T MISS OUT!
Stay up to date on new listings and recieve special offers from our partners.
SIGN UP!
Go on, give it a try, you can unsubscribe anytime.

More from our Blog

Oct 31
Out In the Cold – Harm Reduction Non-Profit Vows to Fight on Despite Eviction

CANNABIS CULTURE – As opioid overdoses skyrocket in the province, the BC Supreme…

Oct 30
The Roll-up #168: Is Shawn Kemp’s Cannabis a Black-owned business?

Former NBA all-star Shawn Kemp is opening Seattle’s first Black-owned cannabis…

Oct 30
Hemp Seeds An Excellent Source Of Omega-3 And Omega-6 Fatty Acids

Hemp seeds are from the hemp plant, Cannabis sativa, the same species (but different…

Oct 30
New Zealand Votes Against Legalizing Cannabis, Preliminary Results Show

New Zealanders voted to legalize euthanasia in a binding referendum, but preliminary…

Oct 30
Isopropyl Alcohol Alternatives for Cleaning Marijuana Resin

The most obvious effects of the Coronavirus pandemic are plastered all over the…

Oct 30
Jay-Z launches Monogram, his own cannabis line

Jay-Z is growing his empire. The 50-year-old rapper and music mogul announced Friday…



DON'T MISS OUT!
Stay up to date on new listings and recieve special offers from our partners.
SIGN UP!
Go on, give it a try, you can unsubscribe anytime.
Close

Join our newsletter and get a fresh stash weekly.

Stay up to date on new resources and information, and receive special offers from our partners.
Subscribe
SUBSCRIBE NOW
close-link